LakeShore Biopharma Co Ltd (LSB)
2.71
-0.39
(-12.58%)
USD |
NASDAQ |
Nov 14, 16:00
2.71
0.00 (0.00%)
After-Hours: 20:00
LakeShore Biopharma Revenue (Quarterly): 13.38M for Sept. 30, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 13.38M |
| June 30, 2023 | 25.15M |
| Date | Value |
|---|---|
| September 30, 2022 | 28.33M |
| June 30, 2022 | 31.08M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
13.38M
Minimum
Sep 2023
31.08M
Maximum
Jun 2022
24.49M
Average
26.74M
Median
Revenue (Quarterly) Benchmarks
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | 3.979M |
| Zai Lab Ltd | 100.50M |
| China SXT Pharmaceuticals Inc | -- |
| Adagene Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.51M |
| Total Expenses (Quarterly) | 27.21M |
| EPS Diluted (Quarterly) | -0.1565 |